|
Market Cap (18-May) $28,597,052 (1,494th) |
Close (18-Oct) $0.270 |
Volume (18-Oct) 0 |
Shortsold (25-Oct) 26,980 (0.03%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.043 |
BDA released this announcement to the ASX on 28 January 2021, 9:46. The announcement is marked as price sensitive, and is 9 page(s) in length and 756.88kb in size.
You can view all announcements from BDA and see how they appear on a price chart on the announcements page.
At the date of this announcement, BDA was 0.015% short sold according to ASIC data. It was ranked the 527th most shorted stock on the ASX. It remains ranked 544th as of the latest reported data (25 October 2021).
| Other Recent Announcements from BDA | |
|---|---|
| Change of ASX code to BOD | 15 October 2021, 13:23 |
| BOD to conduct Schedule 3 clinical trial of new CBD product | 22 September 2021, 9:14 |
| Change in substantial holding | 27 August 2021, 18:58 |
| Quarterly Activities Report and Appendix 4C | 28 January 2021, 9:46 |
| Bod delivers record attributable sales in Q2 FY2021 | 18 January 2021, 9:19 |
| Bod achieves strong second half medicinal cannabis sales | 7 January 2021, 9:32 |
| Change of Director Interest Notices - J Patterson and A Bedi | 31 December 2020, 10:05 |
You must be logged in to post a reply.
Bod Australia 